Artificial Intelligence has the potential to greatly improve clinical care and support the transition to value-based care, but also comes with risks. So what role should AI play in value-based care models? The question was posed last week during a panel discussion at CES 2024 that was moderated by Dr. Jesse Ehrenfeld, president of the American Medical Association.
Chris Jagmin, vice president and chief medical officer of state programs and medical policy at CVS Health’s Aetna, said it’s important to use AI in areas where there is little risk. This includes aiding in clinical decision-making and approving something as an insurer. He added that AI presents opportunities in areas that “drive us crazy,” such as automating call centers or automating claims payment.